Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
NCT03371862 on ClinicalTrials.gov · last registry update 2020-08-14
Withdrawn before anyone was enrolled. The sponsor logged completion for 6 August 2020. Primary outcome, as filed: Improvement in parenteral support.
- Status
- WITHDRAWN
- Phase
- P2
- Drug
- liraglutideSaxenda, Victoza, Xultophy
- Sponsor
- Imperial College London
- Sponsor type
- Other
- Enrollment
- 0
- Started
- 2017-10-20
- Primary completion
- 2020-08-06 actual
Observed history
No changes recorded since monitoring began on 2026-08-21. This record has held steady. If a reporting date moves, a status changes or enrollment is resized, it will appear here with the previous value alongside the new one.
Primary outcome
Improvement in parenteral support
Conditions studied
Short Bowel Syndrome
Every field above is taken directly from the registry record. See all detected changes across the class, or the liraglutide page for this molecule’s full trial and approval history.